Parth Mehrotra - Apr 27, 2023 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Signature
/s/ Thomas Bartrum, as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Apr 27, 2023
Transactions value $
-$28,652
Form type
4
Date filed
5/1/2023, 06:06 PM
Previous filing
Apr 14, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $2.2K +1.1K +1.13% $2.00* 98.5K Apr 27, 2023 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale -$30.9K -1.1K -1.12% $28.00 97.4K Apr 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -1.1K -2.32% $0.00 46.4K Apr 27, 2023 Common Stock 1.1K $2.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2022.
F2 All stock options are fully vested and exercisable.